Oramed Files Fifth Amended and Restated Bylaws

Oramed Pharmaceuticals Inc. filed updated Fifth Amended and Restated Bylaws, revising governance protocols such as shareholder meetings and director elections. This corporate procedural update is unlikely to influence current market trading or operational expectations.